Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Feb 27, 2023
- Accession no.
- 0001022079-23-000035
- Filed
- Feb 27, 2023
- Trade date
- Feb 23-24, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $200.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2023 | Common Stock | FTax withholdingDisposed | −811 | $147.86 | −$119,914.46 | 38,413 | Direct | |
| Feb 23, 2023 | Common Stock | AGrant or awardAcquired | +2,442 | $0.00 | $0 | 40,855 | Direct | |
| Feb 24, 2023 | Common Stock | SSaleDisposed | −1,415 | $141.42 | −$200,109.3 | 39,440 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2023 | Common Stock | AGrant or awardAcquired | +9,653 | $0.00 | $0 | 9,653 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.